Advertisement
Home »

Disease-modifying therapies do not affect sleep quality or daytime sleepiness in a large Australian MS cohort.

Jul 31, 2023

ABOUT THE EXPERTS

  • Jason A Turner

    School of Psychological Sciences, College of Health and Medicine, University of Tasmania, Hobart and Launceston, Australia.

    Laura L Laslett

    Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

    Christine Padgett

    School of Psychological Sciences, College of Health and Medicine, University of Tasmania, Hobart and Launceston, Australia.

    Chai K Lim

    Macquarie Medical School, Macquarie University, Sydney, Australia.

    Bruce Taylor

    Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

    Ingrid van der Mei

    Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

    Cynthia A Honan

    School of Psychological Sciences, College of Health and Medicine, University of Tasmania, Hobart and Launceston, Australia; Launceston General Hospital, Launceston, Tasmania, Australia. Electronic address: Cynthia.Honan@utas.edu.au.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement